Apellis Pharmaceuticals stock just tumbled. Here’s why By Investing.com – Canada Boosts
© Reuters. Apellis Prescription drugs (APLS) inventory simply tumbled. Here is why Apellis Pharma (APLS) inventory skilled a pointy pre-market decline following information that it anticipates a adverse opinion from a European regulator on Pegcetacoplan at its upcoming assembly. The inventory fell 14.1% in early commerce. After receiving a adverse development vote throughout an oral…